GLP-1 drugsReview

Efficacy and Safety of Dual GLP-1/Glucagon Receptor Agonism in Overweight and Obesity: A Class-Specific Systematic Review and Meta-Analysis

Diabetes, Obesity & Metabolism

The paper

Muhammad Maaz Amjad, Muhammad Mustafa Khan, Fatima Sarwar,

Aqsa Ali, Maham Ali, Faiza Bakhash, Humna Abid, Farah Ibrahim, Kashaf Mustafa, Dur‐e‐Najaf Ali, Malik Muhammad Nasr Fayyaz, Huma Hassan, Safwan Masaud Mian, Muhammad Yaseen, Ihsan Qamar, Amir Hamza Khan, Sami Ullah,

Bilal Wazir Khan

Khyber Medical College

Diabetes, Obesity & Metabolism · 29 Sep 2026

doi.org/10.1111/dom.71400 PubMed 42811393

Six blood metabolites distinguish metabolic health in obesity
Frontiers in Endocrinology · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD
Diabetes, Obesity & Metabolism · 4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Diabetes, Obesity & Metabolism · 4 Oct 2026